BR vs FDMT · P/E 16, rev $6.89B vs rev $37.0K
Broadridge Financial Solutions Inc (BR) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
BR currently screens at market cap $17.65B and trailing P/E 16.3. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the BR and FDMT stock pages for the full models.
Not investment advice.